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Human serum albumin (HSA) is a versatile and important protein
for the pharmaceutical industry (Fanali et al., Mol. Aspects Med. 33
(3) (2012) 209–290). Due to the potential transmission of
pathogens from plasma sourced albumin, numerous expression
systems have been developed to produce recombinant HSA (rHSA)
(Chen et al., Biochim. Biophys. Acta (BBA)—Gen. Subj. 1830(12)
(2013) 5515–5525; Kobayashi, Biologicals 34(1) (2006) 55–59).
Based on our previous study showing increased glycation of rHSA
expressed in Asian rice (Frahm et al., J. Phys. Chem. B 116(15)
(2012) 4661–4670), both supplier-to-supplier and lot-to-lot varia-
bility of rHSAs from a number of expression systems were
evaluated using reversed phase liquid chromatography linked
with MS and MS/MS analyses. The data are associated with the
research article ‘Determination of Supplier-to-Supplier and Lot-to-
Lot Variability in Glycation of Recombinant Human Serum
Albumin Expressed in Oryza sativa’ where further analysis of rHSA
samples with additional biophysical methods can be found (Frahm
et al., PLoS ONE 10(9) (2014) e109893). We determined that all
rHSA samples expressed in rice showed elevated levels of arginine
and lysine hexose glycation compared to rHSA expressed in yeast,
suggesting that the extensive glycation of the recombinantElsevier Inc. This is an open access article under the CC BY license
gics and Genetic Therapies Directorate Health Canada, AL 2201E, 251 Sir
0K9 Canada. Tel.: +613 957 1068.
.
D.G.S. Smith et al. / Data in Brief 4 (2015) 583–586584proteins is a by-product of either the expression system or
puriﬁcation process and not a random occurrence.
Crown Copyright & 2015 Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations tableSubject area Biology
More speciﬁc
subject areaRecombinant proteinsType of data Raw Data, Peak Lists, Search Results and Exported Search Results
How data was
acquiredLiquid chromatography–mass spectrometry (LC–MS) analysis—waters nanoAcquity UPLC and waters
synapt HDMS system operating in data dependant acquisition (DDA) mode.Data format Waters raw data (.raw), Mascot generic ﬁle peak lists (.mgf), Mascot search results (.dat) and
exported search results (.mzid)Experimental factors Samples were reduced and then alkylated with iodoacetamide followed by digestion with trypsin
and chymotrypsinExperimental
featuresCommercially available recombinant human serum albumin samples were digested and analyzed by
LC–MS/MSData source location Ottawa, Ontario, Canada
Data accessibility Data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository
(PXD001248 and DOI 10.6019/PXD001248).1. Value of the data [describe in 3–5 bulleted points why this data is of value to the scientiﬁc
community] Represents a robust method for proﬁling variation in glycation of commercial products
 Demonstrates the utility of multi-enzyme approach for extensive protein sequence coverage
allowing detailed analysis/comparison of non-complex proteomic samples
 Provides a model data set for qualitative and quantitative proteomics studies
 Covers the entire data generation/analysis process, from raw data, to processed peak lists, to search
results, to exported result ﬁles.2. Experimental design, materials and methods
As described in ‘Determination of Supplier-to-Supplier and Lot-to-Lot Variability in Glycation of
Recombinant Human Serum Albumin Expressed in Oryza sativa’ [1,2,3,5].3. Materials
Chemicals, essentially FA-free pHSA (A3872 Lot090M7001V, Z99% purity), recombinant human serum
albumin expressed in Saccharomyces cerevisiae (ScrHSA, Lot SLBD2407, Z99% purity, Albucult), O. sativa
[OsrHSA, Lot SLBC7527V (OsrHSA-sig-C), Lot SLBG7405V (OsrHSA-sig-G), Lot SLBH9636V (OsrHSA-sig-H) and
Lot SLBJ1196V (OsrHSA-sig-J) 100% purity, Cellastim] and Pichia pastoris (PprHSA, Lot 080M1580V, Z99%
purity, Albagen) were sourced from Sigma-Aldrich (St. Louis, MO, USA). OsrHSA was also obtained from
eEnzyme LLC (Gaithersburg, MD, USA) (OsrHSA-phy) (Lot 20130110, 499% purity, Phyto-HSA), ScienCell
Research Laboratories (Carlsbad, CA, USA) (OsrHSA-sci) (Lot BJABAA42, Z99% purity, Oryzogen) and amsbio
LLC (Cambridge, MA, USA) (OsrHSA-ams) (Lot 20101008, 495% purity, ecoHSA). Recombumin (Lot
PDP100106) was donated by Novozymes Biopharma (Cambridge, MA, USA). Amicon Ultra 0.5 ml 3000 Da
molecular weight cut-off (MWCO) centrifugal ﬁlter devices were purchased from Millipore (Billerica, MA,
USA). Trypsin and chymotrypsin were Promega sequencing grade purchased from Fisher Scientiﬁc Canada
(Ottawa, ON, Canada). Vivacon 500 10 kDa molecular weight cut-off ﬁlters were from Sartorius Stadium
Biotech North America (Bohemia, NY, USA).
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Albumin samples were prepared as described previously [4]. Brieﬂy, samples were buffer
exchanged into 5 mM sodium phosphate (pH 7.4), with Amicon Ultra 0.5 ml 3000 Da MWCO
centrifugal ﬁlter devices after pre-rinsing the ﬁlters with buffer. Protein concentrations were
measured using a BCA assay kit (Sigma-Aldrich, St. Louis, MO, USA). Protein integrity after buffer
exchange was assessed with 1-D SDSPAGE using SYPRO Ruby protein stain (Molecular Probes,
Eugene, OR, USA) and a Bio-Rad Molecular Imager Gel Doc XRþ system with Quantity One 1-D
analysis software according to the manufacturer’s instructions (Bio-Rad, Mississauga, ON, Canada).5. Liquid chromatography–mass spectrometry (LC–MS) analysis—Sample preparation
For each of the rHSA samples, approximately 10 mg were diluted in 50 mM ammonium bicarbonate
to a total volume of 200 ml. To each solution 10 ml of 250 mM dithiothreitol (DTT) in 50 mM NH4HCO3
were added followed by incubation for 1 h at 60 1C. Next, 20 ml of 250 mM iodoacetamide in 50 mM
NH4HCO3 were added and samples were incubated at room temperature in the dark for 30 min. The
alkylation reactions were quenched by the addition of an additional 20 ml of 250 mM DTT and the
samples were split into 2125 ml aliquots and transferred onto 10 kDa MWCO spin ﬁlters. Samples
were centrifuged for 20 min at 14,000 g then washed with 2200 ml of 50 mM NH4HCO3 in the
same manner.
Trypsin and chymotrypsin solutions were prepared by adding 1000 ml of 50 mM NH4HCO3 to 20 mg
and 25 mg lyophilized protein, respectively. One 125 ml aliquot from each sample was digested with
trypsin and the other with chymotrypsin. Digestion was carried out by spinning 100 ml of trypsin
solution through the ﬁlters at 10,000 g over 20 min, then spinning 100 ml of 50 mM NH4HCO3
through the ﬁlter under the same conditions. The ﬂow through from the digestion steps was collected
in clean tubes and evaporated to dryness in a vacuum centrifuge then re-suspended in 40 ml of
injection solvent (3% acetonitrile, 0.2% formic acid and 0.05% TFA in water) prior to LC–MS/MS
analysis.6. LC–MS analysis—Sample analysis
For each sample, triplicate 2 ml aliquots were analyzed by loading onto a Waters Symmetry C18
trap column (180 mm20 mmwith 5 mm beads) and desalting with 0.1% formic acid in water (solvent
A) for 3 min at 5.0 ml/min before separating on a Waters nanoAcquity UPLC BEH130 C18 reverse phase
analytical column (100 mm100 mm with 1.7 mm beads). Chromatographic separation was achieved
at a ﬂow rate of 0.500 ml/min over 70 min in six linear steps as follows (solvent B was 0.1% formic acid
in acetonitrile): Initial—3% B, 2 min—10% B, 40 min—30% B, 50 min—95% B, 55 min—95% B, 56 min—3%
B, ﬁnal—3% B. The eluting peptides were analyzed by MS and MS/MS using a Waters Synapt HDMS
system operating in data directed acquisition (DDA) mode. MS survey scans were 1 s in duration and
MS/MS data were collected on the four most abundant peaks until either the total ion count exceeded
3000 or until 3 s elapsed. Within each analysis, redundant analyses were limited by excluding selected
peaks 71.15 mass-to-charge (m/z) for 60 s. Between triplicate analyses, previously selected peaks
were prevented from being reanalyzed by using m/z (71.15) and retention time (760 s) as exclusion
criteria. Peaks from singly-charged peptides were also excluded from selection for MS/MS analysis.
The instrument was calibrated prior to sample analysis using the fragmentation products of [Glu1]-
Fibrinopeptide B. Calibration accuracy was maintained throughout the analyses using a nano-lock
spray of 100 fmol/ml [Glu1]-Fibrinopeptide B, which was sampled for 1 s once every 30 s. The lock
mass correction was applied to the data during processing.
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Data were qualitatively analyzed using the Mascot software package, available fromMatrix Science
Ltd. (Boston, MA, U.S.A.). The raw data were processed using Mascot Distiller (version 2.4.2) to create
Mascot Generic Files (MGFs) and database searches were performed using Mascot (version 2.4),
against the human protein entries in the 2013_01 UniProtKB/Swiss-Prot database. MGF ﬁles from the
triplicate analyses of both the trypsin and chymotrypsin digests were combined and submitted as a
single search for each sample. Peptide and MS/MS mass tolerances were 100 ppm and 0.1 Da,
respectively, and semi-tryptic and semi-chymotryptic peptides, from 2þ to 5þ charge state and
having up to three missed cleavages, were considered. Carbamidomethylation of cysteine was
speciﬁed as a ﬁxed modiﬁcation and oxidation of methionine and hexose addition on lysine and
arginine were considered as variable modiﬁcations. The mass spectrometry proteomics data have
been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the
dataset identiﬁer PXD001248 and DOI 10.6019/PXD001248.Acknowledgements
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